Ultra Processed Foods Consumption and Impact in Rheumatic Diseases.

Recruiting now

Conditions studied: Rheumatoid Arthritis, Spondyloarthritis, Osteoarthritis

In brief

Ultra-processed foods (UPF) represent one of the mainstays of today's diet. They are defined by the NOVA classification system. It was demonstrated that UPF consumption was associated with activity of inflammatory bowel diseases with underlying mechanisms not fully identified yet. It is suspected that UPF constituents could modify the gut microbiota, increase intestinal barrier permeability and directly engage immune surveillance systems, effects that could individually or synergistically increase the risk of immunomediated diseases. As some pathophysiological mechanisms are shared among IBD and rheumatic diseases, we have wondered if UPF consumption could be associated with increased risk of rheumatic disease and/or with their activity. Our primary aim will be to study the pattern of UPF consumption in patients with rheumatic diseases. Our secondary objectives will be to study the activity of diseases according to UPF consumption.

Key facts

Study ID

NCT06776965

Run by

Hospices Civils de Lyon

People needed

240

Starts

2025-03-31

Expected to finish

2026-11-30

Last updated by the study team

2025-04-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age > 18 years
• chronic rheumatic disease (Rheumatoid arthritis, spondyloarthritis, osteoarthritis)
• ability to perform questionnaires

You may not qualify if…

• Judicial protection measure
• Refusal to participate in the study
• Suffering from 2 rheumatic disease simultaneously

Where it is running

• Edouard Herriot Hospital — Lyon, France (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.